Blue Lake Biotechnology

Blue Lake Biotechnology is a startup focused on developing human vaccines using novel viral vectors. Its goal is to develop PIV5-based vaccines for human diseases, with an initial focus on respiratory syncytial virus, and it has received FDA approval to proceed to Phase I trials.